drugset / Trial / NCT01091324
Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The investigators test the renal and cardiovascular protective effects dextromethorphan and silymarin on patients with the proteinuric chronic kidney diseases, who enrolled in our clinical trial, had progressing kidney diseases and merit aggressive anti-inflammatory therapy.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-06
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dextromethorphan | Unknown | 60 mg | — |
| Comparator | Silymarin | Traditional medicine (herbal / TCM) | 150 mg | — |